Related Experiment Video
Updated: May 9, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
Amiodarone-induced pulmonary toxicity: case study with syndrome analysis
Theodore E Van Cott1, Karen S Yehle, Susan K DeCrane
1School of Nursing, Purdue University, 502 N. University St., West Lafayette, IN 47906, USA.
Amiodarone can cause serious lung damage, a rare but potentially fatal side effect. This review details amiodarone pulmonary toxicity, covering its causes, symptoms, and management.
Area of Science:
- Cardiology
- Pulmonology
- Pharmacology
Background:
- Amiodarone is a widely used antiarrhythmic drug for atrial and ventricular arrhythmias.
- Despite its efficacy, amiodarone carries a risk of significant adverse effects, including pulmonary toxicity.
Observation:
- Amiodarone-induced pulmonary toxicity presents with symptoms like cough and dyspnea.
- Radiographic findings include infiltrates, potentially progressing to respiratory failure and death.
Findings:
- Pulmonary toxicity from amiodarone, while statistically rare, is a serious concern.
- This review examines a case study to elucidate the pathophysiology, epidemiology, and clinical aspects of this syndrome.
Implications:
- Understanding amiodarone pulmonary toxicity is crucial for appropriate patient management and monitoring.
- Further research is needed to refine diagnostic and therapeutic strategies for this adverse effect.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Drug Toxicity: Risk factors
Acute Coronary Syndrome III: Diagnostic Studies
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions
Cardiomyopathy II: Dilated Cardiomyopathy

